Facebook
X
LinkedIn
ForwardWelcome to the UNCLCN Learning Portal
The UNCLCN Learning Portal contains oncology education videos presented by experts in North Carolina and throughout the US.
View our Live Webinars and Self-Paced Online Courses to earn free continuing education credit!
Free Continuing Education credits are available for:
Physicians, Nurses, Pharmacists, Pharmacy Technicians, Radiologic Technologists, and Oncology Data Specialists
Upcoming Live Webinar
|
Featured Course
 |
Advanced Practice Provider NCPD/CNE • ACPE • ASRT Ilona Fridman, PhD View More Self-Paced, Online Courses |
Ready to Learn!
Please take a look at all our educational offerings. Continuing Education credits are available for healthcare providers in select content.
 | Live Webinars |
 | Self-Paced Online Courses |
 | Educational Series |
 | More about us |
Sign up for our newsletter or follow us on social media!
 |  |  |  |  |
Recent Courses
Mark Woodcock gives a broad overview of the multidisciplinary approaches for the treatment of soft tissue sarcomas in adults, and detailed updates in management with systemic therapies. Specific attention is paid to sarcoma sub-types which may warrant special considerations.
|
Zev Nakamura, MD will present on key topics related to cognitive issues experienced by patients with cancer.
|
Attendees will learn about the benefits of exercise during and after cancer treatment, designing programs that provide maximum benefits, and how to engage patients in increasing their physical activity during and after treatment.
|
Natalie Grover, MD, will review some of the recent advances in the treatment of lymphoma, including the incorporation of novel targeted agents in the frontline treatment of diffuse large B cell lymphoma and Hodgkin lymphoma, the use of CAR-T cell therapy in second-line treatment in diffuse large B cell lymphoma, and recently approved drugs by the FDA for lymphoma.
|
Clarissa Urban, PA-C, will cover the basics of clinical trials for an APP. She will highlight the different phases of trials, the clinical trial team, and documents pertaining to trials. In addition, she will focus on phase 1 clinical trials along with diversity in trial participation.
|
Robyn Tolley, AGPCNP-BC, will identify cytotoxic vesicant and irritant drugs, evaluation of infiltration and extravasation, recommended non-pharmacologic and pharmacologic treatments, and when care should be advanced to involve plastic surgery. She will also include an evaluation of risk factors and appropriate preventive measures to reduce the risk of extravasation.
|